Clinical Trials Browser

Interventional × Solid Tumor × Gastrointestinal × Clear all

NCT03592264 2024-10-15

A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors

Phase 1/2 Terminated

GastrointestinalOther solid neoplasm

Solid Tumor

NCT02423343 2021-09-09

A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma

Phase 1/2 Completed

41 enrolled 21 charts

GastrointestinalOther solid neoplasmThoracic

Solid Tumor